Design and in vitro evaluation of multiparticulate floating drug delivery system of zolpidem tartarate

被引:30
作者
Amrutkar, P. P. [1 ]
Chaudhari, P. D. [2 ]
Patil, S. B. [1 ]
机构
[1] Shriman Sureshdada Jain Coll Pharm, PG Course, Chandwad 423101, Maharashtra, India
[2] Modern Coll Pharm, Pune, Maharashtra, India
关键词
Zolpidem tartarate; Pellets; Floating drug delivery system; Modified release; GASTRORETENTIVE DOSAGE FORMS; HELICOBACTER-PYLORI; GASTRIC RETENTION; RELEASE; MICROSPHERES; FORMULATION; POLYMERS; TABLETS; PELLETS; VIVO;
D O I
10.1016/j.colsurfb.2011.09.011
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Zolpidem tartarate is a non-benzodiazepine, sedative-hypnotic, which finds its major use in various types of insomnia. The present work relates to development of multiparticulate floating drug delivery system based on gas generation technique to prolong the gastric residence time and to increase the overall bioavailability. Modified release dosage form of zolpidem tartarate adapted to release over a predetermined time period, according to biphasic profile of dissolution, where the first phase is immediate release phase for inducing the sleep and the second phase is modified release phase for maintaining the sleep up to 10 h. The system consists of zolpidem tartarate layered pellets coated with effervescent layer and polymeric membrane. The floating ability and in vitro drug release of the system were dependent on amount of the effervescent agent (sodium bicarbonate) layered onto the drug layered pellets, and coating level of the polymeric membrane (Eudragit((R)) NE 300). The system could float completely within 5 min and maintain the floating over a period of 10 h. The multiparticulate floating delivery system of zolpidem tartarate with rapid floating and modified drug release was obtained. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:182 / 187
页数:6
相关论文
共 30 条
[1]   Floating drug delivery systems: A review [J].
Arora, S ;
Ali, J ;
Ahuja, A ;
Khar, RK ;
Baboota, S .
AAPS PHARMSCITECH, 2005, 6 (03) :E372-E390
[2]   Gastroretentive dosage forms:: Overview and special case of Helicobacter pylori [J].
Bardonnet, PL ;
Faivre, V ;
Pugh, WJ ;
Piffaretti, JC ;
Falson, F .
JOURNAL OF CONTROLLED RELEASE, 2006, 111 (1-2) :1-18
[3]   Modeling and comparison of dissolution profiles [J].
Costa, P ;
Manuel, J ;
Lobo, S .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 13 (02) :123-133
[4]  
Dey NS, 2008, TROP J PHARM RES, V7, P1067
[5]  
Ghebre-Sellassie I., 1989, Pharmaceutical pelletization technology
[6]   Development and in vitro evaluation of a novel floating multiple unit dosage form obtained by melt pelletization [J].
Hamdani, Jamila ;
Moes, Andre J. ;
Amighi, Karim .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 322 (1-2) :96-103
[7]   Air compartment multiple-unit system for prolonged gastric residence. Part I. Formulation study [J].
Iannuccelli, V ;
Coppi, G ;
Bernabei, MT ;
Cameroni, R .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 174 (1-2) :47-54
[8]   A NEW MULTIPLE-UNIT ORAL FLOATING DOSAGE SYSTEM .1. PREPARATION AND INVITRO EVALUATION OF FLOATING AND SUSTAINED-RELEASE CHARACTERISTICS [J].
ICHIKAWA, M ;
WATANABE, S ;
MIYAKE, Y .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1991, 80 (11) :1062-1066
[9]   Calcium silicate based microspheres of repaglinide for gastroretentive floating drug delivery: Preparation and in vitro characterization [J].
Jain, SK ;
Awasthi, AM ;
Jain, NK ;
Agrawal, GP .
JOURNAL OF CONTROLLED RELEASE, 2005, 107 (02) :300-309
[10]   The effect of sodium alginate on physical and dissolution properties of Sureleaseo®-matrix pellets prepared by a novel pelletizer [J].
Kim, Min-Soo ;
Kim, Jeong-Soo ;
Hwang, Sung-Joo .
CHEMICAL & PHARMACEUTICAL BULLETIN, 2007, 55 (11) :1631-1634